3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation

Citation
U. Oppitz et al., 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation, RADIOTH ONC, 53(1), 1999, pp. 53-57
Citations number
23
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Onconogenesis & Cancer Research
Journal title
RADIOTHERAPY AND ONCOLOGY
ISSN journal
01678140 → ACNP
Volume
53
Issue
1
Year of publication
1999
Pages
53 - 57
Database
ISI
SICI code
0167-8140(199910)53:1<53:3OGACP>2.0.ZU;2-O
Abstract
Background and purpose: The introduction of computed-tomography as an advan ced planning tool for the irradiation of intracranial tumours led to a cont roversial discussions about the optimal target-volume for the primary and p ostoperative treatment of malignant gliomas. This study analyses the three- dimensional tumour regrowth pattern relative to the treated volume which in cluded the macroscopic preoperative tumour and 2-cm safety margin. Materials and methods: Seventy-nine patients with histologically-confirmed Glioblastoma multiforma and documented recurrence who were irradiated in ou r department between 1990 and 1996 were reviewed. With the help of a comput er program written for this purpose, the PTV of the CT-based treatment plan was reconstructed and its spatial outline compared with the reconstructed volume of the recurrent tumour in the control CT-study. Results: In 33 out 34 patients for which the CT-study showing tumour-recurr ence was available the recurrence was completely situated within the origin al 90%-isodose. Only one tumour surpassed the outside surface of the PTV bu t was predominantly situated within the original tumourbed and suggests a t umour-regrowth within the high dose volume. Conclusions: The above results show that target-volumes based on the preope rative size of the enhanced tumour mass well cover the site of recurrence i n nearly all cases. The findings suggest dose escalation to a more restrict ed volume. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.